Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

6 Stock Charts To Watch: AXSM, BLDP, CCXI, NK, PCG, XPEL

Published 02/04/2020, 03:12 AM
Updated 07/09/2023, 06:31 AM

1. Axsome Therapeutics (AXSM)

Axsome Therapeutics Inc (NASDAQ:AXSM) made an explosive move in Nov, had a three-wave corrective pullback, formed a little bit of a base, and on Monday, it looks like it may have broken out. It jumped 7.05, or 8.12%, to 93.87, with a high of 94.98, on 800,863 shares traded. I’m thinking this is about to pop and retest the highs that come in around 110. I’m looking for 15-18 points here, then we’ll see if it can get through that. If it does, midchannel is beckoning about 145.

2. Ballard Power Systems (BLDP)

Ballard Power Systems Inc (NASDAQ:BLDP) after a big move in Dec, came down hard, bounced, and then pulled back. The pullback came on lower volume, and on Monday, it bounced 62 cents, or 6.28%, closing at the high for the day at 10.49, on 2.8 million shares. It’s got to get up through this pattern. If it does, I wouldn’t be shocked to see it make a more extensive move that takes it into the mid-teens, around 15.

3. ChemoCentryx (CCXI)

ChemoCentryx (NASDAQ:CCXI) made an explosive move in Nov and has been in a rising channel since then. It was in a two-week flag, and on Monday, it was popped out again, gaining 2.47, or 5.8%, to 44.89, with a high of 44.96, on 608,476 shares traded. I think it can go higher. I’m looking for a move into the high 50’s, low 60’s.

4. NantKwest (NK)

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

NantKwest Inc (NASDAQ:NK) is on the verge, in my opinion. It’s similar now to where it was in early Jan. On Monday, it was up 37 cents, or 5.85%, to 6.69, with a high of 6.74, on 910,357 shares traded. It’s going have to pop and go. If it gets through resistance at 7.65, then we’re looking at 10, 12, and 14 going forward.

5. PG&E Corporation (PCG)

Pacific Gas & Electric (NYSE:PCG) had another pop on Monday, jumping 2.06, or 13 1/2%, to 17.27, with a high of 17.40, on 25.5 million shares. That’s the best volume in two months. It looks to me like this is accelerating toward my swing target at 18 1/2-19.

6. XPEL (XPEL)

Xpel (NASDAQ:XPEL) broke out of a wedge on Monday and popped 1.08, or 6.5%, to 17.68, with a high of 17.80, on 348,062 shares traded. I’m looking for a run to get this up towards about 22 1/2.

Stocks on the long side

Akebia Therapeutics, Inc. (AKBA), Axsome Therapeutics, Inc. (AXSM), Bilibili Inc. (BILI), Ballard Power Systems Inc. (BLDP), ChemoCentryx, Inc. (CCXI), Compugen Ltd. (CGEN), CEL-SCI Corporation (CVM), Fate Therapeutics, Inc. (FATE), Forty Seven, Inc. (FTSV), GSX Techedu Inc. (GSX), iQIYI, Inc. (IQ), NIO Inc. (NIO), NantKwest, Inc. (NK), Neoleukin Therapeutics, Inc. (NLTX), PG&E Corporation (PCG), Pieris Pharmaceuticals, Inc. (PIRS), Purple Innovation, Inc. (PRPL), Revance Therapeutics, Inc. (RVNC), Virgin Galactic Holdings, Inc. (SPCE), Square, Inc. (NYSE:SQ), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Trillium Therapeutics Inc. (TRIL), Tesla, Inc. (NASDAQ:TSLA), Acceleron Pharma Inc. (XLRN), XPEL, Inc. (XPEL), and Zoom Video Communications, Inc. (ZM).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.